Lotronex Prescribing Physicians Must Certify Completion Of CME Program
Executive Summary
Physicians prescribing GlaxoSmithKline's Lotronex must first pass a test certifying completion of a special education program, a joint advisory panel recommended April 23
You may also be interested in...
FDA Safety Cmte. Consumer Rep Levin Is Critic Of Speedy Drug Reviews
FDA's Drug Safety & Risk Management Advisory Committee consumer representative Arthur Levin will likely urge closer scrutiny of the safety profile of non-breakthrough drugs during NDA reviews
FDA Safety Cmte. Consumer Rep Levin Is Critic Of Speedy Drug Reviews
FDA's Drug Safety & Risk Management Advisory Committee consumer representative Arthur Levin will likely urge closer scrutiny of the safety profile of non-breakthrough drugs during NDA reviews
GSK Lotronex Risk Management Program Allows For Off-Label Use
GlaxoSmithKline will track prescriptions for Lotronex to gauge use of the irritable bowel syndrome therapy outside of the risk management program